Skip to search formSkip to main contentSkip to account menu

NSC 706744

Known as: MJ-III-65, NSC-706744, NSC706744 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Abstract 4517: Plasma and tumor pharmacokinetics of IV LMP744, a novel indenoisoquinoline topoisomerase I inhibitor, in a canine phase I study
Introduction: LMP744 (NSC706744) is one of 3 indenoisoquinolines being evaluated in pet dogs with lymphoma to define their safety… 
Highly Cited
2003
Highly Cited
2003
Differential induction of topoisomerase I-DNA cleavage complexes by the indenoisoquinoline MJ-III-65 (NSC 706744) and camptothecin: base sequence analysis and activity against camptothecin-resistant…
Camptothecin (CPT) and its derivatives target mammalian DNA topoisomerase I (top1) and are among the most effective novel… 
2003
2003
Activity against Camptothecin-Resistant Topoisomerases I 706744 ) and Camptothecin : Base Sequence Analysis and Complexes by the Indenoisoquinoline MJ-III-65 ( NSC Differential Induction of…
Camptothecin (CPT) and its derivatives target mammalian DNA topoisomerase I (top1) and are among the most effective novel… 
1998
1998
III-65 早期胃癌における脈管侵襲の意義
1984
1984
III-65 リジン過剰投与による膵障害の電顕細胞化学的研究
1973
1973
III-65 比較的稀な腫瘤形成型大腸小腸結核の1手術治験例( 第3回日本消化器外科学会)
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)